Лечение осложнений карциноматоза брюшины -современное состояние проблемы

Бесплатный доступ

Короткий адрес: https://sciup.org/140188055

IDR: 140188055

Список литературы Лечение осложнений карциноматоза брюшины -современное состояние проблемы

  • Аксель Е.М., Давыдов М.И. Заболеваемость и смертность от злокачественных новообразований: Россия, 2000 год//Злокачественные новообразования в России и странах СНГ в 2000. -М.: РОНЦ им. Н.Н. Блохина РАМН, 2002. -С. 85-106.
  • Беляев А.М., Багненко С.Ф., Рухляда Н.В. Внутрибрюшная химиотерапия злокачественных опухолей брюшной полости. Монография. -СПб.: «ЭЛБИ-СПб», 2007. -254 с.
  • Беляев А.М., Захаренко А.А., Кошелев Т.Е. Патогенез карциноматозного асцита//Вестник Российской военно-медицинской академии. -2010. Т. 29, №1. -С. 205-209.
  • Беришвили А.И., Кузнецов В.В., Горбунова В.А., Блюменберг А.Г. Хирургическое лечение рака яичников III-IV стадии//Вестн. хирургии. 2002. -Том 161, № 1. -С. 48-50.
  • Гринев М.В., Беляев A.M., Карачун Р.В. Алгоритм лечения запущенных и осложненных форм колоректального рака. -СПб НИИ им. И.И.Джанелидзе, 2003. -12 с.
  • Давыдов М.И., Аксель Е.М. Заболеваемость злокачественными новообразованиями населения России и стран СНГ в 2007 году//Вестн. Рос. онкол. науч. центра РАМН. -2009. -Т. 20, № 3. -С. 52-90.
  • Жорданиа К.И. Некоторые аспекты хирургического лечения рака яичников//Практ. онкол. -2000. -№4. -С. 19-24.
  • Мерабишвили В.М. Онкологическая служба в Санкт-Петербурге, в районах города в 2007 году//Ежегодник Популяционного ракового регистра. -СПб., 2008. -256 с.
  • Симонов Н.Н., Аксенов А.В., Рыбин Е.П., Олейник В.В. Кишечная непроходимость при распространённых злокачественных опухолях женских половых органов: хирургическая тактика и комбинированные операции//Вестник хирургии. -1999. -Т. 158, № 2. -С. 55-59.
  • Тарасов В.А., Побегалов Е.С., Виноградова М.В., Шаров Ю.К. Хирургическое лечение больных метастатическим раком//Практическая онкология. -СПб., 2005. -Т. 6, № 2. -С. 92-102.
  • Чиссов В.И., Старинский В.В. Состояние онкологической помощи стран СНГ. -М., 2000. -С 48-51.
  • Appleqvist P., Silva J., Salmeda L., Kostianien S. On the treatment and prognosis of malignant ascites; is survival time determined when the abdominal paracentes is is needed?//J. Surg. Oncol. -1982. -Vol. 20. -P. 238.
  • Bhavana P. Percutaneous endoscopic gastrostomy tube placement in patients with malignant bowel obstruction due to ovarian carcinoma//Gynecologic Oncology. -2005. -Vol. 96. -P. 330-334.
  • Bronkskill M.J., Bush R.S., Eye G.N. A quantitative management of peritoneal drainage in malignant ascites//Cancer. -1977. -Vol. 40. -P. 2375.
  • Brown P.D. Matrix metalloproteinase inhibitors//Breast Cancer Res. Treat. -1998. -Vol. 52. -P. 125-136.
  • Brundell S.M., Tucker K., Chatterton B., et al. The effect of lavage on intraabdominal cell barden//Surg. Endosc. -2002. -Vol. 16, № 7. -P. 1064-1067.
  • B. van Ooijen, M.E.L. van der Burg. Surgical treatment or gastric drainage only for intestinal obstruction in patients with carcinoma of the ovary or peritoneal carcinomatosis of other orgin//Surgery. -1993. -Vol. 176, № 5. -P. 469-474.
  • Cannizzaro R. et al. Percutaneous endoscopic gastrostomy as a decompressive technique in bowel obstruction due to abdominal carcinomatosis//Endoscopy. -1995. -Vol. 27, № 4. -P. 317-320.
  • Doglietto G.B., Pacelli F., Caprino P. Surgery: independent prognostic factor in curable and far advanced gastric cancer//World J. Surg. -2000. -Vol. 24, № 4. -P. 459-463.
  • Donald P., Yin-Bun C., Wong N.S. Adrenal insufficiency in intestinal obstruction from carcinomatosis peritonei -a factor of potential importance in symptom palliation//Journal of Pain and Symptom Management. -2005. -Vol. 29, № 4. -P. 411-418.
  • Feldman G.B., Knapp R.C. Lymphatic drainage of the peritoneal cavity and its significance in ovarian cancer//Am. J. Obstet. Gynecol. -1974. -Vol. 119. -P. 991-994.
  • Fujimoto S., Zhang B., Minami S. et al. Evaluation of intraoperative intraperitoneal cytology for advanced gastric carcinoma//Oncology. -2002. -Vol. 62, № 3. -P. 201-208.
  • Gauderer M.V. et al. Gastrostomy without laparotomy: a percutaneous endoscopic technique//J. Pediatr. Surg. -1980. -Vol. 15, № 6. -Р. 872-875.
  • Glockzin G., Schlitt H., Piso P. Review. Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy//World J. Surg. Oncol. -2009. -Vol. 7, № 5. -P. 1-8.
  • Guillemette L., Catherine A., Laetitia S. Protocol for the Treatment of Malignant Inoperable Bowel Obstruction: A Prospective Study of 80 Casesat Grenoble University Hospital Center//Journal of Pain and Symptom Management. -2006. -Vol. 31, № 6. -P. 502-512.
  • Herman L.L. et al. Percutaneous endoscopic gastrostomy for decompression of the stomach and small bowel//Gastrointest. Endosc. -1992. -Vol. 38, № 3. -P. 314-318.
  • Kaibara N., Litsuka Y., Kimura A. et al. Relationship between area of serosal invasion and prognosis in patients with gastric Cancer.//Cancer. -1989. -Vol. 60. -P. 136-139.
  • Koppe M.J., Boerman O.C., Wim J.G. et al. Peritoneal Carcinomatosis of Colorectal Origin. Incidence and Current Treatment Strategies//Ann. Surg. -2006. -Vol. 243, № 2. -P. 212-222.
  • Litsuka Y., Matsui T. Prognosis of gastric cancer in relation to the square of serosal invasion//Jpn. J. Cancer Clin. -1987. -Vol. 33, № 3. -P. 223-225.
  • Lon S., Annest M.D., Philip C., Jolly M.D. The results of surgical treatment of bowel obstruction caused by peritoneal carcinomatosis//The American Surgeon. -1979. -№ 11. -P. 718-721.
  • Malone J.J. et al. Palliationof small bowel obstruction by percutaneous gastrostomy in patients with progressive ovarian carcinoma//Obstet. Gynecol. -1986. -Vol. 68, № 3. -P. 431-433.
  • Maruyama K., Sasako M., Kinoshita Т., Okajima K. Efectiveness of systemic lymph node dissection in gastric cancer surgery//Gastric Cancer. Tokyo: Springer. -1993. -P. 293-305.
  • Mercadante S. et al. Medical Treatment for inoperable malignant bowel obstruction: a qualitative systematic review//Journal of Pain and Symptom Management. -2007. -Vol. 33, № 2. -P. 217-223.
  • Newland R., Chapuis P., Smyth E. The prognostic value of substaging colorectal carcinoma: A prognostic study of 1117 cases with standardized pathology//Cancer. -1987. -Vol. 60. -P. 852-857.
  • Parsons S.L., Watson S.A., Steele R.J. Phase I/II trial of batimastat, a matrix metalloproteinase inhibitor, in patients with malignant ascites//Eur. J. Surg. Oncol. -1997. -Vol. 23. -P. 526-531.
  • Ribeiro U., Gama-Rodrigues J., Safatle-Ribeiro A. Prognostic significance of intraperitoneal free cancer cells obtained by laparoscopic peritoneal lavage in patien ts with gastric cancer//J. Gastrointest. Surg. -1998. -Vol. 2, № 3. -P. 244-249.
  • Ripley R.T., Davis J.L., Kemp C.D. Prospecltive randomized trial evaluating mandatory second look surgery with HIPEC and CRS vs. standard of care in patients at high risk of developing colorectal peritoneal metastases//Trials Journal. -2010. -Vol. 11, № 62. -P. 1-8.
  • Robert L., Glass M.D. Small intestinal obstruction from Peritoneal carcinomatosis//The American Journal of Surgery. -1973. -Vol. 125, № 3. -P. 316-317.
  • Rony A., Yehuda G. Malignant ascites: past, present, and future//J. Am. Coll. Surg. -2004. -Vol. 198. -№ 6. -P. 999-1011.
  • Runyon B.A. Care of patients with ascites//N. Engl. J. Med. -1994. -Vol. 330. -P. 337-342.
  • Sadeghi B., Arvieiix C., Glehen O., Beaujard A.C., Rivove M. Peritoneal carcinomatosis from non-gynecologic malignancies results of the EVOCAPE 1 multicentric prospective study//Cancer. -2000. -Vol. 88. -P. 358-363.
  • Smith E.M., Jayson G.C. The current and future management of malignant ascites//Clin. Oncol. -2003. -Vol. 15. -P. 59-72.
  • Sugarbaker P. H. Management of Peritoneal Carcinomatosis//AMA. -1989. -Vol.16. -P. 57-60.
  • Sugarbaker P.H. Peritonectomy procedures//Ann. Surg. -1995. -Vol. 221. -P. 29-42.
  • Sugarbaker P.H. Management of peritoneal surface malignancy using intraperitoneal chemotherapy and cytoreductive surgery: Manual for Physicians and Nurses \ Washington Cancer Institute. Washington: The Ludann Company Grand Rapids. -1998. -40 p.
  • Sugarbaker P.H. Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis//Semin. Surg. Oncol. -1998. -Vol. 14. -P. 254-261.
  • Sugarbaker P.H. Successful management of microscopic residual disease in large bowel cancer//Cancer Chemother. Pharmacol. -1999. -Vol. 43. -P. 15-25.
  • Sugarbaker P.H. Management of peritoneal-surface malignancy: the surgeon’s role//Langenbecks Arch. Surg. -1999. -Vol. 384. -P. 576-587.
  • Sugarbaker P.H., Yonemura Y. Clinical pathway for the management of respectable gastric cancer with peritoneal seedings: best palliation with a ray of hope for cure//Oncology. -2000. -Vol. 58. -P. 96-107.
  • Sugarbaker P.H. Cytoreductive surgery and perioperative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome//Tumori. -2001. -Vol. 87, № 4. -P. 3-5.
  • Sugarbaker P.H. Cytoreduction including total gastrectomy for pseudomyxoma peritonei//Brit. J. Surg. -2002. -Vol. 89, № 2. -P. 208-212.
  • Sugarbaker P.H. Peritoneum as the first-line of defense in carcinomatosis//Journal of Surgical Oncology. -2007. -Vol. 95. -P. 93-96.
  • Toung R.C. Management of ovarian cancer//Sem. Oncol. -1998. -Vol. 25. -P. 335-338.
  • Turnbull D.M., Guerra J., Fletcher H.S. Results of surgery for obstructing carcinomatosis of gastrointestinal, pancreatic, biliary origin//Journal of Clinical Oncology. -1989. -Vol. 7, № 3. -P. 381-386.
  • Vimal M.D., Anangug P., Samarjit S.G. Intestinal obstruction in carcinomatosis//The American Surgeon. -1980. -№ 12. -P. 691-693.
  • Watson S.A., Morris T.M., Robinson G., et al. Inhibition of organ invasion by the matrix metalloproteinase inhibitor batimastat (BB-94) in two human colon carcinoma metastasis models//Cancer Res. -1995. -Vol. 55. -P. 3629-3633.
  • Wisbeck W.M., Becher E.M., Russel A.H. Adenocarcinoma of the stomach: autopsy observations with therapeutic implications for the radiation oncologist//Radiother. Oncol. -1986. -Vol. 7, № 1. -P. 13-18.
  • Yonemura Y., Fujimura T., Fushida S. Hyperthermochemotherapi combined with citoreductive surgery for the treatment of gastric cancer with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination//World J. Surg. -1991. -Vol. 15, № 4. -P. 530-536.
  • Yonemura Y., Endou Y., Fujita H. et al. Role of MMP-7 in the formation of peritoneal dissemination in gastric cancer//Gastric Cancer. -2000. -Vol. 3, № 2. -Р. 63-70.
  • Yonemura Y., Bandou E., Kinoshita K. et al. Effective therapy for peritoneal dissemination in gastric cancer//Surg. Oncol. Clin. N. Am. -2003. -Vol. 12, № 3. -P. 635-648.
Еще
Статья обзорная